Chapter Member Anniversaries: May 2020

Posted by ISPE Boston
On May 5, 2020

Please congratulate the following members celebrating milestone anniversaries in May 2020. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Karen Conte, Pfizer Timothy W. Crowley, Sentrol, Inc. Michael J. Denault, Denault Associates Daniel M. Duffy, Jr., Sanofi John H. Evers, MS, Lantheus Medical Imaging Joshua Froimson, AbbVie […]

Welcome New Members April 2020!

Posted by ISPE Boston
On May 5, 2020

We would like to introduce the Members who joined ISPE in April 2020, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

New Normal, New Webinar Programming!

Posted by ISPE Boston
On April 30, 2020

The Boston Area Chapter is proud to kick off a series of Thursday webinars in a joint venture with our sister Chapter, Delaware Valley. The first installment on April 23 took as its topic the very reason why webinars have replaced in-person programming: the COVID-19 pandemic. With over 200 attendees tuning in, a group of […]

COVID-19 Webinar Highlights Industry Response

Posted by Caren Jenkins
On April 30, 2020

Last Thursday’s webinar panelists delved deep into the coronavirus pandemic, with a focus on the biopharma industry’s response. Steve Fadden, Georgia Keresty and Marc Pelletier (of J&J, Takeda and CRB Consulting Engineers, respectively) began by describing when they first became aware of the pandemic and what they and their organizational teams did to respond. They […]

Waltham’s TScan Teams with Novartis on T Cell Receptor Cancer Treatments

Posted by ISPE Boston
On April 21, 2020

TScan Therapeutics has announced it will partner with Novartis to discover and develop novel T cell receptor (TCR) engineered T cell therapies. TCR therapies reprogram a patient’s own T cells to recognize shared cancer targets. The collaboration includes an upfront technology access fee and research funding totaling $30 million, and potential milestone payments contingent on […]

Moderna Awarded $483 Million by BARDA for Coronavirus Vaccine

Posted by ISPE Boston
On April 21, 2020

Moderna has been promised up to $483 million from the U.S. Department of Health and Human Services (HHS) Biomedical Advanced Research and Development Authority (BARDA) to accelerate development of its mRNA vaccine candidate (mRNA-1273) against the novel coronavirus (SARS-CoV-2). mRNA-1273 is an mRNA vaccine encoding for a prefusion stabilized form of the Spike (S) protein. […]

Pfizer Teams with BioNTech to Develop COVID-19 Vaccine

Posted by ISPE Boston
On April 21, 2020

Pfizer and Germany’s BioNTech have disclosed additional details of their collaboration, previously announced on March 17, to jointly develop a mRNA COVID-19 vaccine. The effort has the potential to supply millions of vaccine doses by the end of 2020, subject to the technical success of the development program and approval by regulatory authorities, and then […]

NIH and Biopharmas Partner to Speed COVID-19 Vaccine and Treatment Options

Posted by ISPE Boston
On April 21, 2020

The NIH and the Foundation for the NIH (FNIH) are bringing more than a dozen leading biopharmaceutical companies together with governmental agencies to coordinate the research response to the COVID-19 pandemic. The planned Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership will develop a framework for prioritizing vaccine and drug candidates, streamlining clinical trials, coordinating […]

Breakthrough Smartphone-Based Self-Test for COVID-19

Posted by ISPE Boston
On April 21, 2020

Sanofi and California-based Luminostics have signed an agreement to evaluate a collaboration on a unique self-test for COVID-19. Luminostics would contribute its proprietary technology for consumer-diagnostics for COVID-19 testing while Sanofi would bring its clinical research testing experience and capabilities. The goal of the collaboration is to provide a consumer-based test that can detect the […]

Arrakis Inks $190 Million Deal with Roche

Posted by ISPE Boston
On April 16, 2020

Arrakis Therapeutics has entered into a strategic collaboration and license agreement with Roche for the discovery of RNA-targeted small molecule (rSM) drugs against a broad set of targets across all of Roche’s research and development areas. Under the terms of the agreement, Arrakis will lead discovery and research activities for each target to a defined […]

Page 66 of 117«‹64 656667 68 ›»